Climb Bio (CLYM) Ownership - Who Owns Climb Bio?

708 Followers

Climb Bio (CLYM) Ownership Overview

20.12% Insiders

5.46% Mutual Funds

39.82% Other Institutional Investors

2.81% ETFs

31.79% Public Companies and

Individual Investors

The ownership structure of Climb Bio (CLYM) stock is a mix of institutional, retail, and individual investors. Approximately 48.09% of the company’s stock is owned by Institutional Investors, 20.12% is owned by Insiders, and 31.79% is owned by Public Companies and Individual Investors.

The ownership structure of Climb Bio (CLYM) stock is a mix of institutional, retail, and individual investors. Approximately 45.28% of the company’s stock is owned by Institutional Investors, 20.12% is owned by Insiders, and 2.81% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jan 07, 2026	Ra Capital Management, Llc	xxxxxxxxxxxxx	$24889
Dec 15, 2025	Ra Capital Management, Llc	xxxxxxxxxxxxx	$754737

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Ra Capital Management	xxxxxxxxxxxxx	$77411432

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Peter Kolchinsky	11,300,939	Institution	19.74%	129,395,752
	11,300,939	Insider	19.74%	129,395,752
	1,468,417	Institution	2.56%	16,813,375
	1,278,403	Institution	2.23%	14,637,714
	1,147,895	Institution	2.00%	13,143,398
Richard Driehaus	600,946	Institution	1.05%	6,880,832
	258,563	Institution	0.45%	2,960,546
	154,657	Insider	0.27%	1,770,823
	127,678	Institution	0.22%	1,461,913
	123,800	Institution	0.22%	1,417,510

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,468,417	Institution	2.56%	16,813,375
1,147,895	Institution	2.00%	13,143,398
258,563	Institution	0.45%	2,960,546
123,800	Institution	0.22%	1,417,510
39,953	Institution	0.07%	457,462
32,453	Institution	0.06%	371,587
16,894	Institution	0.03%	193,436
15,713	Institution	0.03%	179,914
13,870	Institution	0.02%	158,812
6,842	Institution	0.01%	78,341

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	985,986	Institution	1.72%	10,806,407
Vanguard Extended Market ETF	292,417	Institution	0.51%	3,204,890
iShares Micro-Cap ETF	79,419	Institution	0.14%	909,348
Dimensional U.S. Small Cap ETF	76,929	Institution	0.13%	872,375
ALPS Medical Breakthroughs ETF	57,140	Institution	0.10%	654,253
Avantis U.S Small Cap Equity ETF	35,973	Institution	0.06%	407,934
U.S. Micro Cap Portfolio ETF	28,752	Institution	0.05%	196,951
Virtus LifeSci Biotech Clinical Trials ETF	27,169	Institution	0.05%	311,085
Dimensional U.S. Core Equity 2 ETF	13,817	Institution	0.02%	156,685
Dimensional US Core Equity Market ETF	8,176	Institution	0.01%	92,716

FAQ

Who Owns Climb Bio, Inc. (CLYM)?

According to the latest TipRanks data, approximately 39.82% of the company's stock is held by institutional investors, 20.12% is held by insiders, and 31.79% is held by retail investors.

What percentage of Climb Bio, Inc. (CLYM) stock is held by institutional investors?

According to the latest TipRanks data, approximately 39.82% of Climb Bio, Inc. (CLYM) stock is held by institutional investors.

What percentage of Climb Bio, Inc. (CLYM) stock is held by retail investors?

According to the latest TipRanks data, approximately 31.79% of Climb Bio, Inc. (CLYM) stock is held by retail investors.

Who owns the most shares of Climb Bio, Inc. (CLYM)?

Peter Kolchinsky owns the most shares of Climb Bio, Inc. (CLYM).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.